• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺癌手术后单核细胞的增加会触发远处转移的生长,导致复发。

Increasing monocytes after lung cancer surgery triggers the outgrowth of distant metastases, causing recurrence.

机构信息

Division of General Thoracic Surgery, Department of Surgery, Shiga University of Medical Science, Tsukinowacho, Seta, Otsu City, Shiga, 520-2192, Japan.

出版信息

Cancer Immunol Immunother. 2024 Sep 5;73(11):212. doi: 10.1007/s00262-024-03800-8.

DOI:10.1007/s00262-024-03800-8
PMID:39235612
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11377378/
Abstract

Patients with lung cancer have a high incidence of tumor recurrence even after curative surgical resection. Some reports indicated that immunosuppressive cells induced by surgical stress could contribute to tumor recurrence after surgery; however, the underlying mechanisms are not fully understood. In this study, we found that increased postoperative blood monocytes served as a risk factor for tumor recurrence in 192 patients with non-small cell lung cancer (NSCLC). We established the lung cancer recurrent mouse model after tumor resection and showed that the surgical stress immediately increased the level of serum monocyte chemoattractant protein-1 (MCP-1), which subsequently increased blood monocytes. These blood monocytes were rapidly recruited into distant micrometastases and became tumor growth-promoting tumor associated macrophages (TAMs). Furthermore, even after the blood MCP-1 and monocytes decreased enough 72 h after tumor resection, TAMs in micrometastases remained rich because the MCP-1 secreted by micrometastases themselves continued to recruit monocytes around the tumor. Consequently, tumor resection triggered the outgrowth of distant metastases via the MCP-1-Monocyte-TAM axis. When we administered the MCP-1 inhibitor to the lung cancer recurrent model mice, blood monocytes decreased after tumor resection, and TAMs in micrometastases also dramatically decreased. Finally, peri- and postoperative treatment with the MCP-1 inhibitor suppressed distant metastases after surgery. Targeting the MCP-1-Monocyte-TAM axis may inhibit surgical stress-induced NSCLC recurrence by attenuating postoperative immunosuppressive monocytes in micrometastases.

摘要

肺癌患者即使经过根治性手术切除,仍有很高的肿瘤复发率。一些报道表明,手术应激诱导的免疫抑制细胞可能导致手术后肿瘤复发;然而,其潜在机制尚不完全清楚。在这项研究中,我们发现 192 例非小细胞肺癌(NSCLC)患者术后血单核细胞增多是肿瘤复发的危险因素。我们建立了肿瘤切除后的肺癌复发小鼠模型,结果表明手术应激立即增加了血清单核细胞趋化蛋白-1(MCP-1)的水平,进而增加了血单核细胞。这些血单核细胞迅速招募到远处的微转移灶,并成为促进肿瘤生长的肿瘤相关巨噬细胞(TAMs)。此外,即使在肿瘤切除后 72 小时血 MCP-1 和单核细胞减少足够时,由于微转移灶自身分泌的 MCP-1 继续招募肿瘤周围的单核细胞,微转移灶中的 TAMs 仍然丰富。因此,肿瘤切除通过 MCP-1-单核细胞-TAM 轴触发了远处转移的生长。当我们在肺癌复发模型小鼠中给予 MCP-1 抑制剂时,肿瘤切除后血单核细胞减少,微转移灶中的 TAMs 也显著减少。最后,围手术期应用 MCP-1 抑制剂抑制了手术后的远处转移。靶向 MCP-1-单核细胞-TAM 轴可能通过减弱微转移灶中术后免疫抑制性单核细胞来抑制手术应激诱导的 NSCLC 复发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f8/11377378/97650f9c10f5/262_2024_3800_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f8/11377378/7ef484ddd123/262_2024_3800_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f8/11377378/54ab9155a291/262_2024_3800_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f8/11377378/0f4535ece94f/262_2024_3800_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f8/11377378/c7c0d50780eb/262_2024_3800_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f8/11377378/8e18b3bffa5f/262_2024_3800_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f8/11377378/97650f9c10f5/262_2024_3800_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f8/11377378/7ef484ddd123/262_2024_3800_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f8/11377378/54ab9155a291/262_2024_3800_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f8/11377378/0f4535ece94f/262_2024_3800_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f8/11377378/c7c0d50780eb/262_2024_3800_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f8/11377378/8e18b3bffa5f/262_2024_3800_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f8/11377378/97650f9c10f5/262_2024_3800_Fig6_HTML.jpg

相似文献

1
Increasing monocytes after lung cancer surgery triggers the outgrowth of distant metastases, causing recurrence.肺癌手术后单核细胞的增加会触发远处转移的生长,导致复发。
Cancer Immunol Immunother. 2024 Sep 5;73(11):212. doi: 10.1007/s00262-024-03800-8.
2
Monocyte chemoattractant protein-1 blockade inhibits lung cancer tumor growth by altering macrophage phenotype and activating CD8+ cells.单核细胞趋化蛋白-1 阻断通过改变巨噬细胞表型和激活 CD8+细胞来抑制肺癌肿瘤生长。
Am J Respir Cell Mol Biol. 2011 Feb;44(2):230-7. doi: 10.1165/rcmb.2010-0080OC. Epub 2010 Apr 15.
3
Oct4 promotes M2 macrophage polarization through upregulation of macrophage colony-stimulating factor in lung cancer.Oct4 通过上调肺癌中的巨噬细胞集落刺激因子促进 M2 型巨噬细胞极化。
J Hematol Oncol. 2020 Jun 1;13(1):62. doi: 10.1186/s13045-020-00887-1.
4
Heterogeneity of multiorgan metastases of human lung cancer cells genetically engineered to produce cytokines and reversal using chimeric monoclonal antibodies in natural killer cell-depleted severe combined immunodeficient mice.在自然杀伤细胞缺失的严重联合免疫缺陷小鼠中,对经基因工程改造以产生细胞因子的人肺癌细胞多器官转移的异质性及使用嵌合单克隆抗体进行逆转研究
Cancer Chemother Pharmacol. 1999;43 Suppl:S26-31. doi: 10.1007/s002800051094.
5
The chemokine monocyte chemoattractant protein-1/CCL2 is a promoter of breast cancer metastasis.趋化因子单核细胞趋化蛋白-1/CCL2 是乳腺癌转移的促进因子。
Cell Mol Immunol. 2023 Jul;20(7):714-738. doi: 10.1038/s41423-023-01013-0. Epub 2023 May 19.
6
PIM1/NF-κB/CCL2 blockade enhances anti-PD-1 therapy response by modulating macrophage infiltration and polarization in tumor microenvironment of NSCLC.PIM1/NF-κB/CCL2 阻断通过调节 NSCLC 肿瘤微环境中巨噬细胞浸润和极化增强抗 PD-1 治疗反应。
Oncogene. 2024 Aug;43(33):2517-2530. doi: 10.1038/s41388-024-03100-6. Epub 2024 Jul 14.
7
Chronic stress influences the macrophage M1-M2 polarization balance through β-adrenergic signaling in hepatoma mice.慢性应激通过β肾上腺素能信号影响肝癌小鼠中巨噬细胞 M1-M2 极化平衡。
Int Immunopharmacol. 2024 Sep 10;138:112568. doi: 10.1016/j.intimp.2024.112568. Epub 2024 Jun 26.
8
Depletion of tumor-associated macrophages inhibits lung cancer growth and enhances the antitumor effect of cisplatin.耗竭肿瘤相关巨噬细胞可抑制肺癌生长并增强顺铂的抗肿瘤作用。
Cancer Sci. 2023 Mar;114(3):750-763. doi: 10.1111/cas.15671. Epub 2022 Dec 28.
9
Early Distant Recurrence in Patients With Resected Stage I Lung Cancer: A Case Series of "Blast Metastasis".根治性切除术后 I 期肺癌患者的早期远处复发:“爆炸转移”病例系列。
Clin Lung Cancer. 2021 Jan;22(1):e132-e135. doi: 10.1016/j.cllc.2020.09.002. Epub 2020 Sep 18.
10
SUSD2 promotes tumor-associated macrophage recruitment by increasing levels of MCP-1 in breast cancer.SUSD2通过提高乳腺癌中MCP-1的水平来促进肿瘤相关巨噬细胞的募集。
PLoS One. 2017 May 5;12(5):e0177089. doi: 10.1371/journal.pone.0177089. eCollection 2017.

引用本文的文献

1
Variation in CBC-Derived Inflammatory Biomarkers Across Histologic Subtypes of Lung Cancer: Can Histology Guide Clinical Management?肺癌不同组织学亚型中基于全血细胞计数得出的炎症生物标志物的差异:组织学能否指导临床管理?
Diagnostics (Basel). 2025 Jun 5;15(11):1437. doi: 10.3390/diagnostics15111437.
2
Activin A is deeply involved in the progression of sarcopenia and leads to poor prognosis in lung cancer patients.激活素A与肌肉减少症的进展密切相关,并导致肺癌患者预后不良。
Sci Rep. 2025 Apr 20;15(1):13641. doi: 10.1038/s41598-025-97907-2.
3
White blood cell traits and lung cancer risk: a two-sample mendelian randomization analysis.

本文引用的文献

1
Chronic psychological stress promotes breast cancer pre-metastatic niche formation by mobilizing splenic MDSCs via TAM/CXCL1 signaling.慢性心理应激通过 TAM/CXCL1 信号转导动员脾脏 MDSC 促进乳腺癌转移前生态位形成。
J Exp Clin Cancer Res. 2023 May 20;42(1):129. doi: 10.1186/s13046-023-02696-z.
2
Cutting edges and therapeutic opportunities on tumor-associated macrophages in lung cancer.肺癌中肿瘤相关巨噬细胞的研究进展及治疗机遇
Front Immunol. 2022 Nov 2;13:1007812. doi: 10.3389/fimmu.2022.1007812. eCollection 2022.
3
Depletion of tumor-associated macrophages inhibits lung cancer growth and enhances the antitumor effect of cisplatin.
白细胞特征与肺癌风险:一项两样本孟德尔随机化分析
Sci Rep. 2025 Feb 4;15(1):4227. doi: 10.1038/s41598-025-88366-w.
耗竭肿瘤相关巨噬细胞可抑制肺癌生长并增强顺铂的抗肿瘤作用。
Cancer Sci. 2023 Mar;114(3):750-763. doi: 10.1111/cas.15671. Epub 2022 Dec 28.
4
Postoperative Plasmacytoid Dendritic Cells Secrete IFNα to Promote Recruitment of Myeloid-Derived Suppressor Cells and Drive Hepatocellular Carcinoma Recurrence.术后浆细胞样树突状细胞分泌IFNα以促进髓源性抑制细胞的募集并驱动肝细胞癌复发。
Cancer Res. 2022 Nov 15;82(22):4206-4218. doi: 10.1158/0008-5472.CAN-22-1199.
5
DTX-P7, a peptide-drug conjugate, is highly effective for non-small cell lung cancer.DTX-P7,一种肽类药物偶联物,对非小细胞肺癌具有高度疗效。
J Hematol Oncol. 2022 Jun 3;15(1):73. doi: 10.1186/s13045-022-01274-8.
6
Circulating tumor cells: Towards mechanical phenotyping of metastasis.循环肿瘤细胞:迈向转移的力学表型分析
iScience. 2022 Feb 22;25(3):103969. doi: 10.1016/j.isci.2022.103969. eCollection 2022 Mar 18.
7
Sarcopenia increases the risk of post-operative recurrence in patients with non-small cell lung cancer.肌肉减少症增加了非小细胞肺癌患者术后复发的风险。
PLoS One. 2021 Sep 22;16(9):e0257594. doi: 10.1371/journal.pone.0257594. eCollection 2021.
8
Immunoregulatory Monocyte Subset Promotes Metastasis Associated With Therapeutic Intervention for Primary Tumor.免疫调节单核细胞亚群促进与原发性肿瘤治疗干预相关的转移。
Front Immunol. 2021 Jun 7;12:663115. doi: 10.3389/fimmu.2021.663115. eCollection 2021.
9
FlowCell-enriched circulating tumor cells as a predictor of lung cancer metastasis.FlowCell 富集的循环肿瘤细胞可预测肺癌转移。
Hum Cell. 2021 May;34(3):945-951. doi: 10.1007/s13577-021-00500-8. Epub 2021 Feb 12.
10
Steps in metastasis: an updated review.转移步骤:最新综述。
Med Oncol. 2021 Jan 4;38(1):3. doi: 10.1007/s12032-020-01447-w.